Neonatal sepsis due to coagulase-negative staphylococci.
Elizabeth A Marchant, Guilaine K Boyce, Manish Sadarangani...
https://pubmed.ncbi.nlm.nih.gov/23762094/Actively Recruiting
Led by University of Washington · Updated on 2025-07-28
350
Participants Needed
6
Research Sites
12 weeks
Total Duration
Researchers are evaluating the best timing to advance enteral feeding in very preterm infants born between 25 and 31 weeks gestation who weigh less than 1500 grams at birth. The study aims to find out if starting to increase milk feeds earlier, after one day of small trophic feeds, compared to after three days of trophic feeds, reduces the risk of late-onset sepsis a serious infection occurring after the first 3 days of life without causing more complications. This multi-center, randomized controlled trial compares these two feeding strategies to improve survival and health outcomes in these vulnerable newborns. Infants will be randomly assigned to one of two feeding plans limited trophic feeds for about 24 hours or extended trophic feeds for about 72 hours, both at volumes of 20-25 mLkgday. After the assigned trophic feeding period, enteral feeds will be advanced by about 25-30 mLkgday until full feeding volumes of 140 mLkgday are reached, typically within two weeks. The feeds consist of the infants own mothers milk or donor human milk if the mothers milk is unavailable. The study allows adjustments if signs of feeding intolerance occur. Participants will be closely monitored throughout their hospital stay until around 40 weeks corrected gestational age. Researchers will assess the occurrence of culture-proven late-onset sepsis, length of hospital stay, death, use of intravenous nutrition and central lines, and other complications like necrotizing enterocolitis, brain hemorrhages, lung disease, and eye problems. Growth measurements such as weight, length, and head size changes will also be tracked. This thorough monitoring aims to determine the safest and most effective feeding approach for very preterm infants.
CONDITIONS
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
G
Gregory C Valentine, MD MED FAAP
A
Ariel Salas, MD, MSPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Washington
Lead Sponsor
University of Alabama at Birmingham
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | 1 Day Trophic Feeds then Rapid Advancement | 3 Days Trophic Feeds then Advancement |
|---|---|---|
| What is it? | This approach starts preterm infants on minimal enteral feeds for 1 day before increasing the volume by approximately 30 mL/kg birthweight/day, using either parent's own milk or donor milk. | This protocol begins with minimal enteral feeds for 3 days, then increases feed volume by about 30 mL/kg birthweight/day, using parent's own milk or donor milk. |
| Role in the trial | Investigational intervention designed to evaluate whether a shorter period of minimal feeding improves outcomes in very preterm infants. | Active comparator representing a longer period of minimal feeding before feed volume advancement. |
| Primary use | Tested to see if short-duration minimal feeding followed by faster advancement reduces late onset sepsis, shortens hospital stay, or improves nutrition. | Serves as the comparator to evaluate whether a longer period of minimal feeding impacts infection risk, hospital length, or nutritional status. |
| How it is given or performed | Minimal enteral feeds of 20-25 mL/kg birthweight/day are given for 1 day, then increased daily by around 30 mL/kg until at least 140 mL/kg birthweight/day, using parent's own or donor milk. | Minimal enteral feeds of 20-25 mL/kg birthweight/day are given for 3 days, then increased daily by around 30 mL/kg until at least 140 mL/kg birthweight/day, using parent's own or donor milk. |
| Evidence status | Randomized controlled trials of progressive feeding in preterm infants are ongoing, but definitive published evidence comparing 1-day versus 3-day trophic feeds is limited. Previous studies suggest early advancement may be safe and improve feeding milestones. | Randomized controlled trials support the safety of slower feed advancement in preterm infants, but published evidence comparing prolonged minimal feeding to shorter protocols remains limited. |
| Important limitations | Evidence for optimal duration of trophic feeds in extremely preterm infants remains incomplete. The impact on infection rates and nutritional status is still being determined through ongoing studies. | There are unanswered questions about whether extending minimal feeds for 3 days delays achievement of full volumes or influences risk of late onset sepsis; published data on optimal protocol for very low birthweight infants is limited. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - Up to 36 hours after birth
Participants are screened for eligibility to participate in the trial.
1 visit (in-person, consent and enrollment)
Duration - Up to 2 weeks or until full feeding volumes are reached
Participants receive either limited trophic feeding for 24 hours or extended trophic feeding for 72 hours, followed by progressive advancement of enteral feeds until full feeds are reached. Feeding consists of parent's own milk or donor human milk. Intravenous fluids and nutrition are provided as needed until full enteral feeding is established.
Daily clinical care visits during hospitalization
Duration - Up to hospital discharge, approximately 40 weeks' gestation
Participants are monitored for late onset sepsis and other clinical outcomes until discharge from the neonatal intensive care unit, around 40 weeks' gestation.
Ongoing assessments during hospitalization
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Elizabeth A Marchant, Guilaine K Boyce, Manish Sadarangani...
https://pubmed.ncbi.nlm.nih.gov/23762094/Mike A Carl, I Malick Ndao, A Cody Springman...
https://pubmed.ncbi.nlm.nih.gov/24647013/Alexander B Mohseny, Veerle van Velze, Sylke J Steggerda...
https://pubmed.ncbi.nlm.nih.gov/29063210/C Heilmann, W Ziebuhr, K Becker
https://pubmed.ncbi.nlm.nih.gov/30502487/Chien-Chung Lee, Ye Feng, Yuan-Ming Yeh...
https://pubmed.ncbi.nlm.nih.gov/34690993/Xiaomei Cong, Michelle Judge, Wanli Xu...
https://pubmed.ncbi.nlm.nih.gov/28252573/Itzhak Levy, Jacklin Comarsca, Miriam Davidovits...
https://pubmed.ncbi.nlm.nih.gov/18936982/Christopher J Stewart, Nicholas D Embleton, Emma C L Marrs...
https://pubmed.ncbi.nlm.nih.gov/28701177/M Janes, A Kalyn, J Pinelli...
https://pubmed.ncbi.nlm.nih.gov/10917292/M J Bell, J L Ternberg, R D Feigin...
https://pubmed.ncbi.nlm.nih.gov/413500/University of Washington
Lead Sponsor
University of Alabama at Birmingham
Collaborating Sponsor